Iron deficiency in patients with nonalcoholic fatty liver disease is associated with obesity, female gender, and low serum hepcidin

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 7, 2014, Pages 1170-1178

  Siddique, Asma ^a   Nelson, James E ^a,b   Aouizerat, Bradley ^c   Yeh, Matthew M ^d   Kowdley, Kris V ^a,b   Abrams, Stephanie H ^e   Himes, Ryan ^e   Krisnamurthy, Rajesh ^e   Maldonado, Leanel ^e   Morris, Beverly ^e   Brandt, Patricia ^f   Dasarathy, Srinivasan ^f,g   Dasarathy, Jaividhya ^f   Hawkins, Carol ^f   McCullough, Arthur J ^f,g   Pagadala, Mangesh ^g   Pai, Rish ^g   Sargent, Ruth ^g   Shah, Shetal ^g   Zein, Claudia ^g   Bernstein, Kimberlee ^h   Cecil, Kim ^h   DeVore, Stephanie ^h   Kohli, Rohit ^h   Lake, Kathleen ^h   Podberesky, Daniel ^h   Slaughter, Crystal ^h   Xanthakos, Stavra ^h   Behr, Gerald ⁱ   Lavine, Joel E ^i,q   Mencin, Ali ⁱ   Ovchinsky, Nadia ⁱ   Reynoso, Elena ⁱ   Abdelmalek, Manal F ^j   Bashir, Mustafa ^j   Buie, Stephanie ^j   Diehl, Anna Mae ^j   Guy, Cynthia ^j   Kigongo, Christopher ^j   Pan, Yi Ping ^j   Piercy, Dawn ^j   Wagner, Melissa ^j   Alazraki, Adina ^k   Cleeton, Rebecca ^k   Karpen, Saul ^k   Raviele, Nicholas ^k   Vos, Miriam ^k   Byam, Elizabeth ^l   Chalasani, Naga ^l   Cummings, Oscar W ^l   Fleming, Cynthia ^l   Ghabril, Marwan ^l   Klipsch, Ann ^l   Marri, Smitha ^l   Molleston, Jean P ^l   Ragozzino, Linda ^l   Sandrasegaran, Kumar ^l   Subbarao, Girish ^l   Vuppalanchi, Raj ^l   Pfeifer, Kimberly ^m   Scheimann, Ann ^m   Torbenson, Michael ^m   Arnon, Ronen ⁿ   Boyd, Mariel ⁿ   Amsden, Katie ^o   Fishbein, Mark H ^o   Kirwan, Elizabeth ^o   Mohammad, Saeed ^o   Quinn, Ann ^o   Rigsby, Cynthia ^o   Whitington, Peter F ^o   Barlow, Sarah ^p   Derdoy, Jose ^p   Jain, Ajay ^p   King, Debra ^p   Osmack, Pat ^p   Siegner, Joan ^p   Stewart, Susan ^p   Neuschwander Tetri, Brent A ^p   Romo, Dana ^p   Ang, Brandon ^q   Arroyo, Sandra ^q   Behling, Cynthia ^q   Bhatt, Archana ^q   Collins, Jennifer ^q   Doycheva, Iliana ^q   Durelle, Janis ^q   Hassanein, Tarek ^q   Loomba, Rohit ^q   Middleton, Michael ^q   Newton, Kimberly ^q   Nguyen, Phirum ^q   Noureddin, Mazen ^q   Paiz, Melissa ^q   Patton, Heather ^q   Schwimmer, Jeffrey B ^q   Sirlin, Claude ^q   Ugalde Nicalo, Patricia ^q   Bass, Nathan M ^c   Brandman, Danielle ^c   Ferrell, Linda D ^c   Fleck, Shannon ^c   Gill, Ryan ^c   Hameed, Bilal ^c   Ko, Alexander ^c   Langlois, Camille ^c   Perito, Emily Rothbaum ^c   Qayyum, Aliya ^c   Rosenthal, Philip ^c   Terrault, Norah ^c   Tsai, Patrika ^c   Atla, Pradeep ^c   Hurtado, Cathy ^c   Garcia, Rebekah ^c   Garcia, Sonia ^c   Sheikh, Muhammad ^c   Singh, Mandeep ^c   Cooper, Kara ^r   Horslen, Simon ^r   Hsu, Evelyn ^r   Murray, Karen ^r   Otto, Randolph ^r   Rich, Deana ^r   Yeh, Matthew ^r   Young, Melissa ^r   Boyett, Sherry ^s   Carucci, Laura ^s   Contos, Melissa J ^s   Fuchs, Michael ^s   Jones, Amy ^s   Kraft, Kenneth ^s   Luketic, Velimir A C ^s   Noble, Kimberly ^s   Puri, Puneet ^s   Sandhu, Bimalijit ^s   Sanyal, Arun J ^s   Sargeant, Carol ^s   Schlosser, Jolene ^s   Siddiqui, Mohhamad S ^s   Wolford, Ben ^s   White, Melanie ^s   Ackermann, Sarah ^a   Cooney, Shannon ^a   Coy, David ^a   Gelinas, Katie ^a   Lee, Maximillian ^a   Pierce, Tracey ^a   Mooney, Jody ^a   Siekas, Lacey ^a   Shaw, Cheryl ^a   Wang, Chia ^a   Brunt, Elizabeth M ^t   Fowler, Kathryn ^t   Kleiner, David E ^u   Grave, Gilman D ^v   Doo, Edward C ^w   Hoofnagle, Jay H ^w   Robuck, Patricia R ^w   Sherker, Averell ^w   Belt, Patricia ^x   Clark, Jeanne M ^x   Corless, Erin ^x   Donithan, Michele ^x   Isaacson, Milana ^x   May, Kevin P ^x   Miriel, Laura ^x   Sternberg, Alice ^x   Tonascia, James ^x   Aynur unalp Arida ^x   Natta, Mark Van ^x   Vaughn, Ivana ^x   Wilson, Laura ^x   Yates, Katherine ^x   more..

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f METROHEALTH MEDICAL CENTER   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁱ Columbia University ^*  (United States)

^j DUKE UNIVERSITY MEDICAL CENTER   (United States)

^k EMORY UNIVERSITY   (United States)

^l INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m JOHNS HOPKINS HOSPITAL   (United States)

ⁿ Mount Sinai Kravis Children's Hospital   (United States)

^o NORTHWESTERN UNIVERSITY   (United States)

^p SAINT LOUIS UNIVERSITY   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^s VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^t WASHINGTON UNIVERSITY   (United States)

^u NATIONAL CANCER INSTITUTE   (United States)

^v EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^w NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^x JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

BMI; Ferroportin; Inflammation; NAFLD; NASH CRN; Nutrition

Indexed keywords

HEPCIDIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; IRON; TRANSFERRIN; IL6 PROTEIN, HUMAN;

ADULT; ALASKA NATIVE; ALCOHOL CONSUMPTION; AMERICAN INDIAN; ARTICLE; BLOOD LEVEL; BODY MASS; DIABETES MELLITUS; FEMALE; GENOTYPE; HUMAN; IRON DEFICIENCY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; RISK FACTOR; WAIST CIRCUMFERENCE; AGED; ALASKA; ANCESTRY GROUP; BLOOD; CHEMISTRY; COMPLICATION; DEFICIENCY; MIDDLE AGED; SERUM; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALASKA; BODY MASS INDEX; CONTINENTAL POPULATION GROUPS; FEMALE; HEPCIDINS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; IRON; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RISK FACTORS; SERUM; SEX FACTORS; YOUNG ADULT;

EID: 84902533159     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.11.017     Document Type: Article

References (29)

1. Harris R.J. Nutrition in the 21st century: what is going wrong?. Arch Dis Child 2004, 89:154-158.
2. Wenzel B.J., Stults H.B., Mayer J. Hypoferraemia in obese adolescents. Lancet 1962, 2:327-328.
3. Micozzi M.S., Albanes D., Stevens R.G. Relation of body size and composition to clinical biochemical and hematologic indices in US men and women. Am J Clin Nutr 1989, 50:1276-1281.
4. Menzie C.M., Yanoff L.B., Denkinger B.I., et al. Obesity-related hypoferremia is not explained by differences in reported intakeof heme and nonheme iron or intake of dietary factors thatcan affect iron absorption. JAm Diet Assoc 2008, 108:145-148.
5. Yanoff L.B., Menzie C.M., Denkinger B., et al. Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond) 2007, 31:1412-1419.
6. Bekri S., Gual P., Anty R., et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006, 131:788-796.
7. Tussing-Humphreys L.M., Nemeth E., Fantuzzi G., et al. Elevated systemic hepcidin and iron depletion in obese premenopausal females. Obesity 2010, 18:1449-1456.
8. Nemeth E., Tuttle M.S., Powelson J., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
9. Lee P., Peng H., Gelbart T., et al. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci US A 2005, 102:1906-1910.
10. Tussing-Humphreys L., Frayn K.N., Smith S.R., et al. Subcutaneous adipose tissue from obese and lean adults does not release hepcidin invivo. Scientific World Journal 2011, 11:2197-2206.
11. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
12. Cohen J.C., Horton J.D., Hobbs H.H. Human fatty liver disease: old questions and new insights. Science 2011, 332:1519-1523.
13. Kowdley K.V., Belt P., Wilson L.A., et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2012, 55:77-85.
14. Nelson J.E., Brunt E.M., Kowdley K.V., et al. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations. Hepatology 2012, 56:1730-1740.
15. Neuschwander-Tetri B.A., Clark J.M., Bass N.M., et al. Clinical, laboratory, and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 2010, 52:913-924.
16. Sanyal A.J., Chalasani N., Kowdley K.V., et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. NEngl J Med 2010, 362:1675-1685.
17. Dawson D.A., Grant B.F., Stinson F.S., et al. Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population. Alcohol Clin Exp Res 2005, 29:844-854.
18. Schrier S.L. Causes and diagnosis of anemia due to iron deficiency. UpToDate 2012, Wolters Kluwer Health, Waltham, MA. D.S. Basow (Ed.).
19. Chung M, Moorthy D, Hadar N, etal. Biomarkers for assessing and managing iron deficiency anemia in late-stage chronic kidney disease. Comparative effectiveness review No. 83. Agency for Healthcare Research and Quality. Publication No. 12(13)-EHC140-EF. Rockville, MD: Dept of Health and Human Services,2012.
20. Ganz T., Olbina G., Girelli D., et al. Immunoassay for human serum hepcidin. Blood 2008, 112:4292-4297.
21. Nelson J.E., Wilson L., Brunt E.M., et al. Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology 2011, 53:448-457.
22. Ioannou G.N., Weiss N.S., Kowdley K.V. Relationship between transferrin-iron saturation, alcohol consumption and the incidence of cirrhosis and liver cancer. Clin Gastroenterol Hepatol 2007, 5:624-629.
23. Harrison-Findik D.D., Schafer D., Klein E., et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. JBiol Chem 2006, 281:22974-22982.
24. Costa-Matos L., Batista P., Monteiro N., et al. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls. Eur J Gastroenterol Hepatol 2012, 24:1158-1165.
25. Lasocki S., Millot S., Andrieu V., et al. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia. Crit Care Med 2008, 36:2388-2394.
26. Theurl I., Schroll A., Nairz M., et al. Pathways for the regulation of hepcidin expression in anemia of chronic disease and irondeficiency anemia invivo. Haematologica 2011, 96:1761-1769.
27. Darshan D., Frazer D.M., Wilkins S.J., et al. Severe iron deficiency blunts the response of the iron regulatory gene Hamp and pro-inflammatory cytokines to lipopolysaccharide. Haematologica 2010, 95:1660-1667.
28. Darshan D., Anderson G.J. Interacting signals in the control of hepcidin expression. Biometals 2009, 22:77-87.
29. Stadlmayr A., Aigner E., Steger B., et al. Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. JIntern Med 2011, 270:41-49.